GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,965 | +33.3% | 161,440 | 0.0% | 0.00% | – |
| Q2 2023 | $232,474 | -36.3% | 161,440 | -7.1% | 0.00% | – |
| Q1 2023 | $364,854 | -7.1% | 173,740 | -50.0% | 0.00% | – |
| Q4 2022 | $392,652 | +38.7% | 347,480 | +100.0% | 0.00% | – |
| Q3 2022 | $283,000 | +24.1% | 173,740 | 0.0% | 0.00% | – |
| Q2 2022 | $228,000 | -18.6% | 173,740 | 0.0% | 0.00% | – |
| Q1 2022 | $280,000 | -14.9% | 173,740 | +9.4% | 0.00% | – |
| Q4 2021 | $329,000 | -46.6% | 158,759 | 0.0% | 0.00% | – |
| Q3 2021 | $616,000 | +21.3% | 158,759 | 0.0% | 0.00% | – |
| Q2 2021 | $508,000 | -61.9% | 158,759 | -74.2% | 0.00% | – |
| Q1 2021 | $1,335,000 | -11.2% | 614,994 | -8.4% | 0.00% | – |
| Q4 2020 | $1,504,000 | -19.3% | 671,394 | -3.8% | 0.00% | – |
| Q3 2020 | $1,864,000 | -11.5% | 698,113 | +1.5% | 0.00% | – |
| Q2 2020 | $2,106,000 | +61.9% | 688,083 | +3.7% | 0.00% | – |
| Q1 2020 | $1,301,000 | -32.2% | 663,783 | -1.1% | 0.00% | – |
| Q4 2019 | $1,919,000 | -6.0% | 671,117 | +20.7% | 0.00% | – |
| Q3 2019 | $2,041,000 | -4.6% | 556,124 | +7.9% | 0.00% | – |
| Q2 2019 | $2,140,000 | +325.4% | 515,546 | +423.9% | 0.00% | – |
| Q1 2019 | $503,000 | +50.1% | 98,403 | +0.9% | 0.00% | – |
| Q4 2018 | $335,000 | +28.4% | 97,558 | +124.9% | 0.00% | – |
| Q3 2018 | $261,000 | -13.9% | 43,378 | -8.8% | 0.00% | – |
| Q2 2018 | $303,000 | +265.1% | 47,550 | +172.5% | 0.00% | – |
| Q1 2018 | $83,000 | +219.2% | 17,450 | +52.4% | 0.00% | – |
| Q3 2017 | $26,000 | -7.1% | 11,450 | 0.0% | 0.00% | – |
| Q2 2017 | $28,000 | +3.7% | 11,450 | 0.0% | 0.00% | – |
| Q1 2017 | $27,000 | +145.5% | 11,450 | 0.0% | 0.00% | – |
| Q4 2016 | $11,000 | -15.4% | 11,450 | 0.0% | 0.00% | – |
| Q3 2016 | $13,000 | -23.5% | 11,450 | -3.0% | 0.00% | – |
| Q2 2016 | $17,000 | 0.0% | 11,809 | 0.0% | 0.00% | – |
| Q1 2016 | $17,000 | -5.6% | 11,809 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | -35.7% | 11,809 | 0.0% | 0.00% | – |
| Q3 2015 | $28,000 | -15.2% | 11,809 | 0.0% | 0.00% | – |
| Q2 2015 | $33,000 | -95.2% | 11,809 | -94.2% | 0.00% | – |
| Q1 2015 | $686,000 | +0.7% | 204,416 | +3.9% | 0.00% | – |
| Q4 2014 | $681,000 | -22.5% | 196,700 | +13.1% | 0.00% | – |
| Q3 2014 | $879,000 | -62.6% | 173,967 | +2.2% | 0.00% | – |
| Q2 2014 | $2,350,000 | – | 170,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |